Petar Vasilev
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Petar Vasilev has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
- Aleksandar Ivanov
Department of General and Clinical Pathology, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria
2 shared publications - Angel Todev
Department of Infectious Diseases, Parasitology and Tropical Medicine, Faculty of Medicine, Medical University, 4002 Plovdiv, Bulgaria
2 shared publications - Marianna Murdjeva
Department of Microbiology and Virology, Medical University of Pleven, 5800 Pleven, Bulgaria
2 shared publications Mariyana Stoycheva
Department of Infectious Diseases, Parasitology and Tropical Medicine Faculty of Medicine Medical Uni- versity -Plovdiv
2 shared publications- Mariyana Stoycheva
Research Institute, Medical University-Plovdiv, 4002 Plovdiv, Bulgaria
2 shared publications - Yordan Kalchev
Department of Medical Microbiology and Immunology, Faculty of Medicine, Medical University of Plovdiv, 4002 Plovdiv, Bulgaria
2 shared publications
Latest Publications
- Open Access
Severe HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes
Acute hepatitis B virus (HBV) infection is rare during infancy, and severe symptomatic HBV-associated hepatitis is even less common. We describe two siblings who developed severe HBV-associated liver injury during infancy, two years apart, but experienced markedly divergent clinical outcomes. Clinical, laboratory, virological, microbiological, imaging, therapeutic, and follow-up data were retrospectively reviewed. Household members were subsequently tested for HBV and HDV. The first infant, a 5-month-old girl, presented with HBsAg positivity, negative serological markers for HAV, HCV, and HEV, and severe acute liver injury with a fulminant clinical course that resulted in death. Because anti-HBc IgM, HBV DNA, repeat HBsAg testing, and follow-up serology were unavailable, acute HBV infection could not be confirmed, and the episode was therefore classified as presumed HBV-associated fulminant hepatitis. The rapidly fatal clinical course precluded a comprehensive etiological evaluation, and the available medical records did not fully document the diagnostic work-up. The second patient, a 4-month-old boy, presented with serological and molecular evidence of acute HBV infection, including low-level HBV DNA, total anti-HDV positivity of uncertain clinical significance, and positive CMV IgM/IgG serology. He also had a urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Without HDV RNA and CMV DNA testing, active HDV infection and clinically significant CMV disease could not be definitively confirmed, while passive transfer of maternal anti-HDV antibodies could not be excluded. The patient required prolonged hospitalization, during which he received supportive, replacement, and antimicrobial therapy. He recovered, and long-term follow-up demonstrated HBsAg clearance with undetectable HBV DNA. Testing of household members revealed chronic HBV infection in the mother and maternal grandmother, both of whom had detectable HDV RNA, consistent with ongoing HBV/HDV circulation within the family. However, without viral sequence data from the infants, the source, route, timing, and direction of transmission could not be established. These cases illustrate the potential severity of HBV-associated hepatitis during infancy and its highly variable clinical outcomes. They also underscore the importance of antenatal HBV screening, timely immunoprophylaxis, and cautious interpretation of suspected viral coinfections when molecular confirmation is unavailable.
Open AccessSevere HBV-Associated Hepatitis in Infants from the Same Family: Two Clinical Cases with Different Outcomes
Acute hepatitis B virus (HBV) infection is rare during infancy, and severe symptomatic HBV-associated hepatitis is even less common. We describe two siblings who developed severe HBV-associated liver injury during infancy, two years apart, but experienced markedly divergent clinical outcomes. Clinical, laboratory, virological, microbiological, imaging, therapeutic, and follow-up data were retrospectively reviewed. Household members were subsequently tested for HBV and HDV. The first infant, a 5-month-old girl, presented with HBsAg positivity, negative serological markers for HAV, HCV, and HEV, and severe acute liver injury with a fulminant clinical course that resulted in death. Because anti-HBc IgM, HBV DNA, repeat HBsAg testing, and follow-up serology were unavailable, acute HBV infection could not be confirmed, and the episode was therefore classified as presumed HBV-associated fulminant hepatitis. The rapidly fatal clinical course precluded a comprehensive etiological evaluation, and the available medical records did not fully document the diagnostic work-up. The second patient, a 4-month-old boy, presented with serological and molecular evidence of acute HBV infection, including low-level HBV DNA, total anti-HDV positivity of uncertain clinical significance, and positive CMV IgM/IgG serology. He also had a urinary tract infection (UTI) caused by extended-spectrum β-lactamase (ESBL)-producing Escherichia coli. Without HDV RNA and CMV DNA testing, active HDV infection and clinically significant CMV disease could not be definitively confirmed, while passive transfer of maternal anti-HDV antibodies could not be excluded. The patient required prolonged hospitalization, during which he received supportive, replacement, and antimicrobial therapy. He recovered, and long-term follow-up demonstrated HBsAg clearance with undetectable HBV DNA. Testing of household members revealed chronic HBV infection in the mother and maternal grandmother, both of whom had detectable HDV RNA, consistent with ongoing HBV/HDV circulation within the family. However, without viral sequence data from the infants, the source, route, timing, and direction of transmission could not be established. These cases illustrate the potential severity of HBV-associated hepatitis during infancy and its highly variable clinical outcomes. They also underscore the importance of antenatal HBV screening, timely immunoprophylaxis, and cautious interpretation of suspected viral coinfections when molecular confirmation is unavailable.
- Open Access
- 27 March 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (4) , 750
Fatal Septic Shock Caused by Enterotoxigenic Escherichia coli O128 and Rare Polymicrobial Co-Infection with Streptococcus equi Subsp. zooepidemicus, Klebsiella oxytoca and Enterococcus durans in a Patient with Liver Cirrhosis: A Case Report
Escherichia coli, Streptococcus equi subsp. zooepidemicus, Klebsiella oxytoca, and Enterococcus durans are microorganisms capable of causing severe infections, particularly in patients with underlying comorbidities or immune dysfunction. We report a rare clinical case of a 65-year-old man with advanced cardiac and hepatic disease who developed severe diarrheal syndrome followed by septic shock, rapid clinical deterioration, and death. Microbiological examination of autopsy specimens from the intestinal wall and spleen identified Escherichia coli O128 with an enterotoxigenic profile (lt+, st+, eae−), together with Streptococcus equi subsp. zooepidemicus, Klebsiella oxytoca, and Enterococcus durans. Histopathological analysis demonstrated catarrhal enteritis with fibrinous deposits, mucosal edema, vascular congestion, and inflammatory infiltration. Although the microbiological findings were partly derived from autopsy material and postmortem bacterial translocation cannot be completely excluded, the concordance between clinical presentation, laboratory findings, and morphological changes supports the presence of a clinically significant infectious process. To our knowledge, this is the first reported human case of fatal polymicrobial infection involving these four pathogens. The case highlights the potential severity of polymicrobial infections in patients with cirrhosis-associated immune dysfunction and underscores the importance of integrated microbiological and molecular diagnostics for accurate etiological assessment.
- 27 March 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (4) , 750
Open AccessFatal Septic Shock Caused by Enterotoxigenic Escherichia coli O128 and Rare Polymicrobial Co-Infection with Streptococcus equi Subsp. zooepidemicus, Klebsiella oxytoca and Enterococcus durans in a Patient with Liver Cirrhosis: A Case Report
Escherichia coli, Streptococcus equi subsp. zooepidemicus, Klebsiella oxytoca, and Enterococcus durans are microorganisms capable of causing severe infections, particularly in patients with underlying comorbidities or immune dysfunction. We report a rare clinical case of a 65-year-old man with advanced cardiac and hepatic disease who developed severe diarrheal syndrome followed by septic shock, rapid clinical deterioration, and death. Microbiological examination of autopsy specimens from the intestinal wall and spleen identified Escherichia coli O128 with an enterotoxigenic profile (lt+, st+, eae−), together with Streptococcus equi subsp. zooepidemicus, Klebsiella oxytoca, and Enterococcus durans. Histopathological analysis demonstrated catarrhal enteritis with fibrinous deposits, mucosal edema, vascular congestion, and inflammatory infiltration. Although the microbiological findings were partly derived from autopsy material and postmortem bacterial translocation cannot be completely excluded, the concordance between clinical presentation, laboratory findings, and morphological changes supports the presence of a clinically significant infectious process. To our knowledge, this is the first reported human case of fatal polymicrobial infection involving these four pathogens. The case highlights the potential severity of polymicrobial infections in patients with cirrhosis-associated immune dysfunction and underscores the importance of integrated microbiological and molecular diagnostics for accurate etiological assessment.
- Open Access
- 4 November 2025
- Published by MDPI AG in Preprints.org
Co-Infection by Escherichia coli O128, Streptococcus equi subsp zooepidemicus, Klebsiella oxytoca and Enterococcus durans, Ended Fatally–A Clinical Case
Escherichia coli, Streptococcus equi subsp zooepidemicus, Klebsiella oxytoca and Enterococcus durans cause a wide range of diseases in both animals and humans. These microorganisms are associated with fatal disease in immunocompromised and comorbid patients. The aim of this study is to present a rare clinical case of an unusual mixed infection of the indicated pathogens, which ended fatally. We found no such clinical case described in a patient with a fatal outcome in our literature review. We present a 65-year-old man admitted at the Clinic of Infectious Diseases, St. George University Hospital, Plovdiv, with severe diarrheal syndrome in a state of toxic-infectious shock. Patient has been ill for 2 days with general weakness, chest and abdominal pain, fever, and about 10 liquid, light brownish stools daily, without mucus and blood. One day before the onset of complaints, he consumed green salad and lamb. He has some accompanying diseases-chronic heart and liver failure with complications. After hospitalization, the patient's condition rapidly worsened, leading to death. Escherichia coli and Streptococcus equi subsp zooepidemicus were isolated from the microbiological examination of cadaver material from the intestinal wall, and from the spleen Klebsiella oxytoca and Enterococcus durans. Histological examination confirmed catarrhal enteritis with characteristic changes–fibrinous plaques, edema in the wall and mucosa and inflammatory infiltrate. To our knowledge, the present clinical case is the first report of a mixed infection by these four pathogens.
- 4 November 2025
- Published by MDPI AG in Preprints.org
Open AccessCo-Infection by Escherichia coli O128, Streptococcus equi subsp zooepidemicus, Klebsiella oxytoca and Enterococcus durans, Ended Fatally–A Clinical Case
Escherichia coli, Streptococcus equi subsp zooepidemicus, Klebsiella oxytoca and Enterococcus durans cause a wide range of diseases in both animals and humans. These microorganisms are associated with fatal disease in immunocompromised and comorbid patients. The aim of this study is to present a rare clinical case of an unusual mixed infection of the indicated pathogens, which ended fatally. We found no such clinical case described in a patient with a fatal outcome in our literature review. We present a 65-year-old man admitted at the Clinic of Infectious Diseases, St. George University Hospital, Plovdiv, with severe diarrheal syndrome in a state of toxic-infectious shock. Patient has been ill for 2 days with general weakness, chest and abdominal pain, fever, and about 10 liquid, light brownish stools daily, without mucus and blood. One day before the onset of complaints, he consumed green salad and lamb. He has some accompanying diseases-chronic heart and liver failure with complications. After hospitalization, the patient's condition rapidly worsened, leading to death. Escherichia coli and Streptococcus equi subsp zooepidemicus were isolated from the microbiological examination of cadaver material from the intestinal wall, and from the spleen Klebsiella oxytoca and Enterococcus durans. Histological examination confirmed catarrhal enteritis with characteristic changes–fibrinous plaques, edema in the wall and mucosa and inflammatory infiltrate. To our knowledge, the present clinical case is the first report of a mixed infection by these four pathogens.
- 28 May 2024
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 30 (2) , 5542-5544
THE LONG ARM OF COVID-19
Chickenpox is often described as a benign disease. However, patients with varicella and coinfection with COVID-19 may develop severe respiratory infection. The interest in the presented case arose from the unusual fast progress of the chickenpox which led to a lethal outcome in a patient with unsuspected COVID-19, proven by PCR after his death. The underlying disease – cancer of the tongue was in remission and wasn’t a cause for immunosuppression which could be a reason for the clinical course of the disease. Aim: To present an interesting case of a 44-year-old man with a previous diagnosis of oral cancer who died after he was diagnosed with varicella and tested positive postmortem for COVID-19. Patient and method: A 44-year-old patient was admitted to the hospital urgently and stayed for 3 and a half hours in the clinic of infectious diseases of UMHAT "St. George", Plovdiv, with a diagnosis of varicella. The patient has accompanying diseases like oral cancer (root of the tongue) and hypertension. Epidemiological data are for contact and fresh infection with varicella, progressing rapidly and beginning of symptoms of respiratory insufficiency and lethal outcome. Due to the fulminant course and the short period of time, the positive PCR result for COVID-19 was proved after the patient died. Conclusions: Unsuspected comorbidity of COVID-19 and varicella without any other reason for immunosuppression could induce unusual severe course of the chickenpox.
- 28 May 2024
- Published by Peytchinski Publishing Ltd. in Journal of IMAB – Annual Proceeding (Scientific Papers)
- Vol. 30 (2) , 5542-5544
THE LONG ARM OF COVID-19
Chickenpox is often described as a benign disease. However, patients with varicella and coinfection with COVID-19 may develop severe respiratory infection. The interest in the presented case arose from the unusual fast progress of the chickenpox which led to a lethal outcome in a patient with unsuspected COVID-19, proven by PCR after his death. The underlying disease – cancer of the tongue was in remission and wasn’t a cause for immunosuppression which could be a reason for the clinical course of the disease. Aim: To present an interesting case of a 44-year-old man with a previous diagnosis of oral cancer who died after he was diagnosed with varicella and tested positive postmortem for COVID-19. Patient and method: A 44-year-old patient was admitted to the hospital urgently and stayed for 3 and a half hours in the clinic of infectious diseases of UMHAT "St. George", Plovdiv, with a diagnosis of varicella. The patient has accompanying diseases like oral cancer (root of the tongue) and hypertension. Epidemiological data are for contact and fresh infection with varicella, progressing rapidly and beginning of symptoms of respiratory insufficiency and lethal outcome. Due to the fulminant course and the short period of time, the positive PCR result for COVID-19 was proved after the patient died. Conclusions: Unsuspected comorbidity of COVID-19 and varicella without any other reason for immunosuppression could induce unusual severe course of the chickenpox.
- Open Access
- 31 August 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1271
Conversion and Obsessive–Phobic Symptoms Predict IL-33 and IL-28A Levels in Individuals Diagnosed with COVID-19
The first epidemiological wave of the incidence of COVID-19 in Bulgaria was registered in June 2020. After the wave peak, we conducted a study in persons diagnosed with COVID-19 (N = 52). They were assessed with the anxiety–depressive scale (ADS), including basic (BS), vegetative (VS), conversion (CS), obsessive–phobic (OPS), and depressive (DS) symptoms. ADS assessment of individuals diagnosed with SARS-CoV-2 indicated a correlation between OPS and IL-33 values. IL-10 levels were higher than reference ranges in all patients. Multiple linear regression analyses demonstrated that combination of CS and OPS explained 28% of IL-33 levels, while combination of symptoms from all ADS dimensions explained 24% of IL-33 levels. It was also found that 21% of IL-28A levels was explained from the combination by all ADS dimensions, whereas OPS was the predictor for lower concentrations. The obtained results revealed meaningful correlations between psycho neuro–immunological factors in pathogenesis of illness from the coronavirus infection.
- 31 August 2023
- Published by MDPI AG in Brain Sciences
- Vol. 13 (9) , 1271
Open AccessConversion and Obsessive–Phobic Symptoms Predict IL-33 and IL-28A Levels in Individuals Diagnosed with COVID-19
The first epidemiological wave of the incidence of COVID-19 in Bulgaria was registered in June 2020. After the wave peak, we conducted a study in persons diagnosed with COVID-19 (N = 52). They were assessed with the anxiety–depressive scale (ADS), including basic (BS), vegetative (VS), conversion (CS), obsessive–phobic (OPS), and depressive (DS) symptoms. ADS assessment of individuals diagnosed with SARS-CoV-2 indicated a correlation between OPS and IL-33 values. IL-10 levels were higher than reference ranges in all patients. Multiple linear regression analyses demonstrated that combination of CS and OPS explained 28% of IL-33 levels, while combination of symptoms from all ADS dimensions explained 24% of IL-33 levels. It was also found that 21% of IL-28A levels was explained from the combination by all ADS dimensions, whereas OPS was the predictor for lower concentrations. The obtained results revealed meaningful correlations between psycho neuro–immunological factors in pathogenesis of illness from the coronavirus infection.
- Open Access
- 30 April 2023
- Published by Pensoft Publishers in Folia Medica
- Vol. 65 (2) , 343-347
When two viruses collide: coronavirus disease after hepatitis B virus reactivation
The COVID-19 pandemic has exploded since the first cases were reported in Wuhan in December 2019, engulfing the globe. Many infected individuals are asymptomatic or have a mild or moderate disease. A subset of people with advanced age, the immunocompromised and those with chronic diseases, are prone to serious-to-critical illness. We report a fatal case of metastatic colorectal cancer survivor who developed COVID-19 after clinically reactivated hepatitis B virus (HBV) due to chemotherapy. The patient’s COVID-19 illness was supposed to be related to her recent medical evaluation. Although being diagnosed with chronic HBV infection for decades, she was not treated with nucleotide analogue and the possibility to preclude HBV reactivation was missed. Moreover, infectious control practices must be draconian in order to save such a fragile population from infections.
- 30 April 2023
- Published by Pensoft Publishers in Folia Medica
- Vol. 65 (2) , 343-347
Open AccessWhen two viruses collide: coronavirus disease after hepatitis B virus reactivation
The COVID-19 pandemic has exploded since the first cases were reported in Wuhan in December 2019, engulfing the globe. Many infected individuals are asymptomatic or have a mild or moderate disease. A subset of people with advanced age, the immunocompromised and those with chronic diseases, are prone to serious-to-critical illness. We report a fatal case of metastatic colorectal cancer survivor who developed COVID-19 after clinically reactivated hepatitis B virus (HBV) due to chemotherapy. The patient’s COVID-19 illness was supposed to be related to her recent medical evaluation. Although being diagnosed with chronic HBV infection for decades, she was not treated with nucleotide analogue and the possibility to preclude HBV reactivation was missed. Moreover, infectious control practices must be draconian in order to save such a fragile population from infections.
- Open Access
- 14 October 2022
- Published by National Center of Infectious and Parasitic Diseases in PROBLEMS of Infectious and Parasitic Diseases
- Vol. 50 (1) , 12-18
COMPARATIVE ASSESSMENT OF THE NUMBER AND IMMUNOLOGICAL STATUS OF NEWLY DIAGNOSED AND RE-ENROLLED IN CARE HIV+ IN THE PERIOD 2018–2019 AND 2020-2021
BACKGROUND: HIV infection has not been shown to be an individual risk factor, but people living with HIV and co-morbidities are at increased risk of severe COVID-19. For HIV+ individuals with severe immunosuppression and/or uncontrolled viremia, the prognosis for the course and outcome of COVID-19 remains serious. HIV infected with low CD4+ T-cell counts before antiretroviral therapy (ART) had a higher risk of complications from COVID-19 than those with higher CD4+ T-cell counts. The aim of the study is to make a comparative assessment of the number and immunological status of newly registered and re-enrolled in care people living with HIV in the period 2018-2019 and 2020-2021 and to look for a correlation with COVID-19 pandemic . MATERIALS AND METHODS: The study included all people living with HIV, monitored at the Clinic of Infectious Diseases and Parasitology, “St. George” University Hospital - Plovdiv both newly diagnosed and re-enrolled in care. Patients were divided into two groups: (1) Evaluated between 01.01.2018 and 31.12.2019 and (2) between 01.01.2020 and 15.10.2021. For the purposes of the study, methods of epidemiological and clinical analysis, ELISA, Western Blot for the diagnosis of HIV/AIDS and flow cytometry for the determination of T-cell populations were used. RESULTS: For the period 2018-2019, there were 82 newly diagnosed and 29 re-enrolled in care HIV + patients. In 42,5% (35/82) of the newly diagnosed the number of CD4 cells was over 350 cells/ µl, in 19.5% (16/82) - between 200 and 350 cells/ µl, in 7% (6/82) - between 100 and 200 cells/ µl l and in 31% (25/82) below 100 cells/ µl. In 24% (7/29) of the re-enrolled the number of CD4 cells was above 350 cells/ µl, in 7% (2/29) - between 200 and 350 cells/ µl, in 21% (6/29) - between 100-200 cells/ µl and in 48% (14/29) - below 100 cells/ µl. For the period 2020-2021, there were 63 newly diagnosed and 34 re-enrolled in care HIV + patients. In 46% (29/63) of the newly diagnosed the number of CD4 cells was over 350 cells/ µl, in 21% (13/63) - between 200 and 350 cells/ µl, in 14% (9/63) -between 100 and 200 cells/ µl and in 19% (12/63) - below 100 cells/ µl. In 30 % (10/34) of the restarted, the number of CD4 cellswas over 350 cells/ µl, in 11% (4/34) - between 200 and 350 cells/ µl, in 15% (5/34) between 100 and 200 cells/ µl and in 44% (15/34) of patients - less than 100 cells/ µl IN CONCLUSION: During the period 2020-2021, 10% fewer new HIV + patients were registered as compared to the period 2018-2019. The late presenters, with CD4 <350 cells/ µl were 58% in the period 2018-2019 vs. 54% in the period 2020 -2021. The late presenters with advanced immune deficiency (CD4 <100cells / µl) were respectively 31% and 19%. The proportion of those re-enrolled in care with advanced immune deficiency (CD4 <100/ml) was 48% in the first group and 44% in the second group, respectively. The lower number of newly diagnosed HIV + patients could be explained with the fear of visiting hospitals, testing getting infected with SARS CoV-2. According to our data, Covid-19 pandemic did not significantly affect the immune status of people living with HIV .
- 14 October 2022
- Published by National Center of Infectious and Parasitic Diseases in PROBLEMS of Infectious and Parasitic Diseases
- Vol. 50 (1) , 12-18
Open AccessCOMPARATIVE ASSESSMENT OF THE NUMBER AND IMMUNOLOGICAL STATUS OF NEWLY DIAGNOSED AND RE-ENROLLED IN CARE HIV+ IN THE PERIOD 2018–2019 AND 2020-2021
BACKGROUND: HIV infection has not been shown to be an individual risk factor, but people living with HIV and co-morbidities are at increased risk of severe COVID-19. For HIV+ individuals with severe immunosuppression and/or uncontrolled viremia, the prognosis for the course and outcome of COVID-19 remains serious. HIV infected with low CD4+ T-cell counts before antiretroviral therapy (ART) had a higher risk of complications from COVID-19 than those with higher CD4+ T-cell counts. The aim of the study is to make a comparative assessment of the number and immunological status of newly registered and re-enrolled in care people living with HIV in the period 2018-2019 and 2020-2021 and to look for a correlation with COVID-19 pandemic . MATERIALS AND METHODS: The study included all people living with HIV, monitored at the Clinic of Infectious Diseases and Parasitology, “St. George” University Hospital - Plovdiv both newly diagnosed and re-enrolled in care. Patients were divided into two groups: (1) Evaluated between 01.01.2018 and 31.12.2019 and (2) between 01.01.2020 and 15.10.2021. For the purposes of the study, methods of epidemiological and clinical analysis, ELISA, Western Blot for the diagnosis of HIV/AIDS and flow cytometry for the determination of T-cell populations were used. RESULTS: For the period 2018-2019, there were 82 newly diagnosed and 29 re-enrolled in care HIV + patients. In 42,5% (35/82) of the newly diagnosed the number of CD4 cells was over 350 cells/ µl, in 19.5% (16/82) - between 200 and 350 cells/ µl, in 7% (6/82) - between 100 and 200 cells/ µl l and in 31% (25/82) below 100 cells/ µl. In 24% (7/29) of the re-enrolled the number of CD4 cells was above 350 cells/ µl, in 7% (2/29) - between 200 and 350 cells/ µl, in 21% (6/29) - between 100-200 cells/ µl and in 48% (14/29) - below 100 cells/ µl. For the period 2020-2021, there were 63 newly diagnosed and 34 re-enrolled in care HIV + patients. In 46% (29/63) of the newly diagnosed the number of CD4 cells was over 350 cells/ µl, in 21% (13/63) - between 200 and 350 cells/ µl, in 14% (9/63) -between 100 and 200 cells/ µl and in 19% (12/63) - below 100 cells/ µl. In 30 % (10/34) of the restarted, the number of CD4 cellswas over 350 cells/ µl, in 11% (4/34) - between 200 and 350 cells/ µl, in 15% (5/34) between 100 and 200 cells/ µl and in 44% (15/34) of patients - less than 100 cells/ µl IN CONCLUSION: During the period 2020-2021, 10% fewer new HIV + patients were registered as compared to the period 2018-2019. The late presenters, with CD4 <350 cells/ µl were 58% in the period 2018-2019 vs. 54% in the period 2020 -2021. The late presenters with advanced immune deficiency (CD4 <100cells / µl) were respectively 31% and 19%. The proportion of those re-enrolled in care with advanced immune deficiency (CD4 <100/ml) was 48% in the first group and 44% in the second group, respectively. The lower number of newly diagnosed HIV + patients could be explained with the fear of visiting hospitals, testing getting infected with SARS CoV-2. According to our data, Covid-19 pandemic did not significantly affect the immune status of people living with HIV .
- Open Access
- 31 August 2021
- Published by Pensoft Publishers in Folia Medica
- Vol. 63 (4) , 576-581
Coinfection of the intestinal tract with Aeromonas hydrophila, Clostridium difficile and Rotavirus - a case report
Most cases of acute diarrhea in adults are of infectious etiology, likely viral and self-limited. Among those with severe diarrhea, however, bacterial causes are responsible for most cases.Apart from the standard stool cultures, to increase the positive yield a novel multiplex molecular test can be performed simultaneously. The authors present a patient with recurrent diarrhea and detection of Aeromonas hydrophila by culturing and Rotavirus and Clostridioides difficile by multiplex molecular test. They discuss and justify which is the most likely actionable pathogen. Good communication between the physicians and interpretation on the multiple positive results in the context of clinical picture and the test employed were important for a better management and favourable outcome of the patient.
- 31 August 2021
- Published by Pensoft Publishers in Folia Medica
- Vol. 63 (4) , 576-581
Open AccessCoinfection of the intestinal tract with Aeromonas hydrophila, Clostridium difficile and Rotavirus - a case report
Most cases of acute diarrhea in adults are of infectious etiology, likely viral and self-limited. Among those with severe diarrhea, however, bacterial causes are responsible for most cases.Apart from the standard stool cultures, to increase the positive yield a novel multiplex molecular test can be performed simultaneously. The authors present a patient with recurrent diarrhea and detection of Aeromonas hydrophila by culturing and Rotavirus and Clostridioides difficile by multiplex molecular test. They discuss and justify which is the most likely actionable pathogen. Good communication between the physicians and interpretation on the multiple positive results in the context of clinical picture and the test employed were important for a better management and favourable outcome of the patient.